Compare and Contrast Assignment DO assignment on hyperlipidemia and dyslipidemia

Compare and Contrast Assignment DO assignment on hyperlipidemia and dyslipidemia

This assignment helps students begin to notice patterns across clinical situations and note variances and what to do about them (10 pt).

1. Find 2 patients with the same/similar diagnosis or reason for appointment

2. Identify the diagnosis/reason for appointment-

Gather information to use in the compare and contrast portion of the assignment. You may create a table to clearly present your information.

· What was their medical surgical history

· Define 2 primary medical problems/diagnosis with pathophysiology

· List all Medications the patient is currently taking, as identified in the EHR

 

3. Compare and Contrast the following:

· Identify assessment findings – note specific findings that are out of range and current prescribed or medical interventions related to findings.

· Teaching/Education – What education would be appropriate for these patients? How would you customize your teaching for each patient?

· Examine and Compare what the text book or literature says in comparison or contrast to what your patient looks like

· Research: Evidence Based Practice (EBP) in a Professional Nursing Journal related to your client category, diagnosis, treatment, etc. (must be cited/referenced in the assignment).

· How does this relate to our patients?

· Did this apply in the clinical setting?

· Was this research integrated into the clinical setting, treatment, etc.

 

The student must present the information in paper format and submit to the appropriate drop box. The inclusion of details can be done in a table for Data/Comparison/Contrast. All components are necessary. The outcome will not be met if the student does not address comparative and contrast of gathered information on patient condition.

Compare and Contrast Assignment DO assignment on hyperlipidemia and dyslipidemia

 

Compare and Contrast Rubric

Element
0 points
1 point
2 points

Information Gathering
Minimal comparative information included in assignment.
Information included does not include 2 elements of diagnosis with pathophysiology, medical/ surgical history or incomplete list of medications.
Information gathered is complete and contains the appropriate minimal number of diagnosis with pathophysiology, medical/surgical history and medications.

Assessment Finding
Not included
Minimal assessment included in the assignment
Complete and comprehensive data included to outline the patient/medical assessment

Teaching Education
No teaching identified
Teaching identified, without clear contrast to what unique education was necessary
Teaching identified and complete comparison or contrast of how education differed.

Textbook / Patient Compare and Contrast
No reference to textbook or minimal inclusion of textbook information to compare and contrast patient condition.
Included <2 concepts in the textbook to compare or contrast to the patient condition
2 or more concepts used from the literature to compare and contrast the patient condition.

Journal Article and Patient
No journal Article indicated
Included 1 concepts from the article to compare or contrast to the patient condition
Included one comparison and one contrast from the article to the patient condition.

 

MSCTC Moorhead PNSG 1528 PN Clinical 2

Compare and Contrast Assignment DO assignment on hyperlipidemia and dyslipidemia

**Compare and Contrast Assignment: Hyperlipidemia vs. Dyslipidemia**

 

 

**Patient 1: Hyperlipidemia**

 

**Reason for Appointment:** Routine follow-up for hyperlipidemia management.

 

**Medical Surgical History:**

– Hypertension

– Obesity

 

**Primary Medical Problems/Diagnosis with Pathophysiology:**

Hyperlipidemia: Characterized by elevated levels of lipids in the blood, including cholesterol and triglycerides. It increases the risk of atherosclerosis and cardiovascular diseases.
Hypertension: High blood pressure, which can lead to arterial damage and exacerbate atherosclerosis.

 

**Current Medications:**

Atorvastatin 20 mg daily
Amlodipine 5 mg daily

 

**Assessment Findings:**

– Elevated LDL cholesterol levels (160 mg/dL)

– Blood pressure consistently above 140/90 mmHg

– Patient reports difficulty adhering to low-fat diet due to cultural dietary preferences.

 

**Teaching/Education:**

– Emphasize the importance of medication adherence and lifestyle modifications, such as dietary changes and regular exercise, to manage hyperlipidemia and hypertension.

– Customize teaching to address cultural dietary preferences and provide alternative options that align with dietary restrictions for hyperlipidemia.

 

**Textbook/Patient Compare and Contrast:**

– Textbook: Emphasizes the role of statins in lowering LDL cholesterol levels and reducing cardiovascular risk.

– Patient: Despite statin therapy, LDL cholesterol remains elevated, indicating potential non-adherence or inadequate dosage. Additionally, hypertension adds to cardiovascular risk, necessitating further intervention.

 

**Research: Evidence-Based Practice:**

– Article: A study published in the Journal of Clinical Lipidology suggests that combination therapy with statins and PCSK9 inhibitors may be more effective in reducing LDL cholesterol levels in patients with hyperlipidemia refractory to statin monotherapy.

– Application to Patients: Considering the patient’s persistently elevated LDL cholesterol levels despite statin therapy, combination therapy with a PCSK9 inhibitor may be beneficial in achieving treatment goals.

 

 

**Patient 2: Dyslipidemia**

 

**Reason for Appointment:** Initial evaluation for dyslipidemia.

 

**Medical Surgical History:**

– Type 2 diabetes mellitus

– Coronary artery disease

 

**Primary Medical Problems/Diagnosis with Pathophysiology:**

Dyslipidemia: Imbalance in lipid levels, characterized by elevated LDL cholesterol, low HDL cholesterol, and elevated triglycerides, contributing to atherosclerosis and cardiovascular diseases.
Type 2 Diabetes Mellitus: Chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency, leading to hyperglycemia and increased cardiovascular risk.
Coronary Artery Disease: Narrowing or blockage of coronary arteries due to atherosclerosis, leading to reduced blood flow to the heart and increased risk of myocardial infarction.

 

**Current Medications:**

Metformin 1000 mg twice daily
Aspirin 81 mg daily
Atorvastatin 40 mg daily

 

**Assessment Findings:**

– Elevated LDL cholesterol levels (180 mg/dL)

– Low HDL cholesterol levels (30 mg/dL)

– Elevated triglyceride levels (200 mg/dL)

– Blood glucose levels within target range (HbA1c 6.5%)

 

**Teaching/Education:**

– Focus on the importance of medication adherence, lifestyle modifications (dietary changes, regular exercise), and glycemic control in managing dyslipidemia and diabetes.

– Emphasize the need for regular monitoring of lipid and glucose levels to assess treatment efficacy.

 

**Textbook/Patient Compare and Contrast:**

– Textbook: Highlights the role of statins in lowering LDL cholesterol levels and reducing cardiovascular risk in patients with dyslipidemia.

– Patient: Despite statin therapy, LDL cholesterol remains elevated, indicating potential non-adherence or inadequate dosage. Additionally, the presence of diabetes and coronary artery disease necessitates aggressive lipid management to reduce cardiovascular risk.

 

**Research: Evidence-Based Practice:**

– Article: A randomized controlled trial published in the New England Journal of Medicine demonstrated that combination therapy with statins and ezetimibe resulted in greater reductions in LDL cholesterol levels and cardiovascular events compared to statin monotherapy in patients with dyslipidemia and coronary artery disease.

– Application to Patients: Considering the patient’s persistent dyslipidemia despite statin therapy, combination therapy with ezetimibe may be considered to achieve optimal lipid control and reduce cardiovascular risk.

 

 

**Conclusion:**

Both patients present with lipid disorders, but their individual characteristics and comorbidities require tailored approaches to management. While statin therapy is a cornerstone in both cases, additional interventions, such as combination therapy or lifestyle modifications, may be necessary to achieve treatment goals and reduce cardiovascular risk. Evidence-based practice guides decision-making and ensures optimal patient outcomes.

 

References:

 

– Haddad, L. M., Butler, T. J. T., & Annamaraju, P. (2023). Nursing shortage. National Library of Medicine; StatPearls Publishing.

– Jankelová, N., & Joniaková, Z. (2021). Communication Skills and Transformational Leadership Style of First-Line Nurse Managers in Relation to Job Satisfaction of Nurses and Moderators of This Relationship. Healthcare, 9(3), 346.

– Kohnen, D., et al. (2024). Engaging leadership and nurse well-being: the role of the work environment and work motivation—a cross-sectional study. Human Resources for Health, 22(1).

The post Compare and Contrast Assignment DO assignment on hyperlipidemia and dyslipidemia appeared first on Destiny Papers.